Whether managing clinical data, or assessing drug safety, or documenting reports during clinical trials, pharmaceutical companies have begun engaging with outsourcing partners to manage these non-core processes. CIBL has thought leaderships having deep and broad experience in this industry (prior association with IMS Health Inc, Novatis etc) which leverage CIBL to design cost-effective solutions for pharmaceutical and bio-medical companies.

• Increasing pressure to maximize the potential of Pharma Research programs
• Achieving maximum effectiveness in drug development processes
• Designing and Implementing Launch Management Planning

Extensive experience of leadership and a keen focus on the Lifesciences and Healthcare industry have encouraged CIBL to build trust-based relationships with its clients. CIBL aims to acquire the position of a major third party provider of clinical research BPO in Bangladesh and South East Asia, and commits to develop expertise to manage processes across:

• Clinical Data Management
• Medical Writing
• Statistical Analysis
• Launch Management

• By leveraging people, corporate network, technology, processes, and infrastructure, CIBL aims to work closely with pharmaceutical enterprises to ensure their drug development processes run at maximum efficiency.
• CIBL’s Innovative Delivery Model ensures customers benefit from high quality results and reduced risks at low costs across the geography.